Cargando…

Synthesis, Pharmacological Evaluation, and Computational Studies of Cyclic Opioid Peptidomimetics Containing β(3)-Lysine

Our formerly described pentapeptide opioid analog Tyr-c[D-Lys-Phe-Phe-Asp]NH(2) (designated RP-170), showing high affinity for the mu (MOR) and kappa (KOR) opioid receptors, was much more stable than endomorphine-2 (EM-2) in the rat brain homogenate and displayed remarkable antinociceptive activity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wtorek, Karol, Lipiński, Piotr F. J., Adamska-Bartłomiejczyk, Anna, Piekielna-Ciesielska, Justyna, Sukiennik, Jarosław, Kluczyk, Alicja, Janecka, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747000/ https://www.ncbi.nlm.nih.gov/pubmed/35011383 http://dx.doi.org/10.3390/molecules27010151

Ejemplares similares

Design, Synthesis and Functional Analysis of Cyclic Opioid Peptides with Dmt-Tic Pharmacophore
por: Sarkar, Arijit, et al.
Publicado: (2020)

Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors
por: Wtorek, Karol, et al.
Publicado: (2019)

Synthesis, Biological Activity and Molecular Docking of Chimeric Peptides Targeting Opioid and NOP Receptors
por: Wtorek, Karol, et al.
Publicado: (2022)

Functional selectivity of EM-2 analogs at the mu-opioid receptor
por: Piekielna-Ciesielska, Justyna, et al.
Publicado: (2023)

Pharmacological Characterization of µ-Opioid Receptor Agonists with Biased G Protein or β-Arrestin Signaling, and Computational Study of Conformational Changes during Receptor Activation
por: Piekielna-Ciesielska, Justyna, et al.
Publicado: (2020)

Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist–Neurokinin Antagonist Peptidomimetics
por: Gadais, Charlène, et al.
Publicado: (2021)

Antinociceptive potency of a fluorinated cyclopeptide Dmt-c[D-Lys-Phe-p-CF(3)-Phe-Asp]NH(2)
por: Piekielna-Ciesielska, Justyna, et al.
Publicado: (2018)

Macrocyclization strategies for cyclic peptides and peptidomimetics
por: Bechtler, Clément, et al.
Publicado: (2021)

Apoptosis-mediated cytotoxic effects of parthenolide and the new synthetic analog MZ-6 on two breast cancer cell lines
por: Wyrębska, Anna, et al.
Publicado: (2012)

Similarity analysis, synthesis, and bioassay of antibacterial cyclic peptidomimetics
por: Berhanu, Workalemahu M, et al.
Publicado: (2012)

Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery
por: Lee, Yeon Sun
Publicado: (2022)

Influence of Open Chain and Cyclic Structure of Peptidomimetics on Antibacterial Activity in E. coli Strains
por: Sahrawat, Parul, et al.
Publicado: (2022)

Bifunctional Opioid/Melanocortin Peptidomimetics for Use in Neuropathic Pain: Variation in the Type and Length of the Linker Connecting the Two Pharmacophores
por: Witkowska, Ewa, et al.
Publicado: (2022)

Isocyanide-based multicomponent reactions towards cyclic constrained peptidomimetics
por: Koopmanschap, Gijs, et al.
Publicado: (2014)

Synthesis of novel sulfide-based cyclic peptidomimetic analogues to solonamides
por: Brango-Vanegas, José, et al.
Publicado: (2019)

Bis-Cyclic Guanidine Heterocyclic Peptidomimetics as Opioid Ligands with Mixed μ-, κ- and δ-Opioid Receptor Interactions: A Potential Approach to Novel Analgesics
por: McLaughlin, Jay P., et al.
Publicado: (2022)

Structure–Activity Relationships of 7-Substituted Dimethyltyrosine-Tetrahydroisoquinoline Opioid Peptidomimetics
por: Montgomery, Deanna, et al.
Publicado: (2019)

Cyclic Peptidomimetic Lead Compounds to Reduce Neurotoxicity and Associated Oxidative Stress in Alzheimer’s Disease
por: Banerjee, Antara, et al.
Publicado: (2010)

Improvement on Permeability of Cyclic Peptide/Peptidomimetic: Backbone N-Methylation as A Useful Tool
por: Li, Yang, et al.
Publicado: (2021)

Peptidomimetics II
por: Lubell, William D
Publicado: (2016)

Peptidomimetics in cancer targeting
por: Gomari, Mohammad Mahmoudi, et al.
Publicado: (2022)

Placement of Hydroxy Moiety on Pendant of Peptidomimetic Scaffold Modulates Mu and Kappa Opioid Receptor Efficacy
por: Harland, Aubrie A., et al.
Publicado: (2017)

Effects of a novel cyclic RGD peptidomimetic on cell proliferation, migration and angiogenic activity in human endothelial cells
por: Fanelli, Roberto, et al.
Publicado: (2014)

Investigating the Interaction of Cyclic RGD Peptidomimetics with α(V)β(6) Integrin by Biochemical and Molecular Docking Studies
por: Civera, Monica, et al.
Publicado: (2017)

Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development
por: Staśkiewicz, Agnieszka, et al.
Publicado: (2021)

Development of Peptidomimetics Targeting IAPs
por: Sharma, Sushil K., et al.
Publicado: (2006)

Using the ribosome to synthesize peptidomimetics
por: Freidinger, Roger M
Publicado: (2009)

Short Cationic Peptidomimetic Antimicrobials
por: Kuppusamy, Rajesh, et al.
Publicado: (2019)

Promising Antibiofilm Activity of Peptidomimetics
por: Gomes Von Borowski, Rafael, et al.
Publicado: (2018)

Peptidomimetics Therapeutics for Retinal Disease
por: Parsons, Dylan E., et al.
Publicado: (2021)

Cell-free Biosynthesis of Peptidomimetics
por: Lee, Kanghun, et al.
Publicado: (2023)

Structural evidence of the species-dependent albumin binding of the modified cyclic phosphatidic acid with cytotoxic properties
por: Sekula, Bartosz, et al.
Publicado: (2016)

Structural Studies Provide New Insights into the Role of Lysine Acetylation on Substrate Recognition by CARM1 and Inform the Design of Potent Peptidomimetic Inhibitors
por: Zhang, Yurui, et al.
Publicado: (2021)

Peptides and Peptidomimetics as Inhibitors of Enzymes Involved in Fibrillar Collagen Degradation
por: Ledwoń, Patrycja, et al.
Publicado: (2021)

A Structural Overview of Vascular Endothelial Growth Factors Pharmacological Ligands: From Macromolecules to Designed Peptidomimetics
por: Ye, Xiaoqing, et al.
Publicado: (2021)

Design, Pharmacological Characterization, and Molecular Docking of Minimalist Peptidomimetic Antagonists of α(4)β(1) Integrin
por: Baiula, Monica, et al.
Publicado: (2023)

Insights into the Binding of Cyclic RGD Peptidomimetics to α(5)β(1) Integrin by using Live‐Cell NMR And Computational Studies
por: Guzzetti, Ileana, et al.
Publicado: (2016)

Fentanyl Structure as a Scaffold for Opioid/Non-Opioid Multitarget Analgesics
por: Lipiński, Piotr F. J., et al.
Publicado: (2022)

Structure Based Antibody-Like Peptidomimetics
por: Murali, Ramachandran, et al.
Publicado: (2012)

Heterocycles in Peptidomimetics and Pseudopeptides: Design and Synthesis (†)
por: Cerminara, Iole, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_buriordoufmj43jsbaogue4sii